| abstract |
The present invention relates to the use of peroxisome proliferator-activated receptor (PPAR) activators and benzoquinones for the treatment and / or prevention of disorders characterized by endothelial dysfunction, such as cardiovascular disease, stroke, and myocardial infarction. Regarding the combination and its use. According to a preferred embodiment of the present invention, benzoquinone or precursor thereof, ubiquinone or precursor thereof, more preferably from coenzyme Q 10 or a precursor thereof, PPAR activators fibrate or thiazolidinedione, more preferably fenofibrate Fibrate. [Selection diagram] Fig. 1 |